Browse > Home / News / Eli Lilly, Chi-Med Team Up on Cancer Drugs

Eli Lilly, Chi-Med Team Up on Cancer Drugs

Eli Lilly & Co. announced it will work with a unit of Hutchison China MediTech Ltd., known as Chi-Med, to develop drugs to treat cancer and inflammatory diseases. Lilly will hand over preclinical research and development on several compounds to the pharmaceuticals company. Chi-Med, which is listed on London’s Alternative Investment Market, is a subsidiary of Hutchison Whampoa Ltd.
Read Original Post Here


Rate this company:
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading ... Loading ...

Posted by: on Thursday, August 23rd, 2007